The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease.
Farlow
Martin R
MR
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005702:Galantamine / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D018697:Nootropic Agents; D005702:Galantamine